Skip to main content
Article

Drug evaluation: Tagatose in the treatment of type 2 diabetes and obesity

Current Opinion in Investigational Drugs
ISSN: 14724472
13Citations
Citations of this article
31Readers
Mendeley users who have this article in their library.

Abstract

Spherix Inc (formerly Biospherics) is developing tagatose, an orally active lactose derivative for the potential treatment of obesity and type 2 diabetes. The compound is also under investigation for the potential treatment of anemia, hemophilia and medical problems related to infertility, birth weight and excessive maternal food intake. Phase I and II clinical trials have been completed. © The Thomson Corporation.

References Powered by Scopus

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study

British Medical Journal
7562Citations
N/AReaders
Get full text

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: Variations with increasing levels of HbA<inf>1c</inf>

Diabetes Care
1354Citations
N/AReaders
Get full text

Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: Meta-analysis of seven long-term studies

European Heart Journal
611Citations
N/AReaders
Get full text
View more at Scopus

Cited by Powered by Scopus

Tagatose: Properties, applications, and biotechnological processes

Applied Microbiology and Biotechnology
206Citations
N/AReaders
Get full text

Tagatose, a new antidiabetic and obesity control drug

Diabetes, Obesity and Metabolism
167Citations
N/AReaders
Get full text

The acid tolerant l-arabinose isomerase from the food grade Lactobacillus sakei 23K is an attractive d-tagatose producer

Bioresource Technology
64Citations
N/AReaders
Get full text
View more at Scopus

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Moore, M. C. (2006, October). Drug evaluation: Tagatose in the treatment of type 2 diabetes and obesity. Current Opinion in Investigational Drugs.

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 11

65%

Researcher 3

18%

Professor / Associate Prof. 2

12%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 5

36%

Agricultural and Biological Sciences 4

29%

Biochemistry, Genetics and Molecular Bi... 3

21%

Pharmacology, Toxicology and Pharmaceut... 2

14%

Save time finding and organizing research with Mendeley

Sign up for free